| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9da4ffd81af6fafaff32faa1f0a1afdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5a9f51ef690ed8682c3cf2c41ec50c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee0bc095744575a6d32ea2c2c8402f7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_130b49f348a64eca51c2ef4ca3021b2e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate |
2010-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2ce0f50972f6de6ae5b519512fd0886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfde6829c4c812ed732cdf9c8fcc795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc087faa2d4040a4cd9182e9e1a1c7ca |
| publicationDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012107320-A1 |
| titleOfInvention |
Antibodies specifically directed to the soluble form of ctla-4 |
| abstract |
The invention provides materials and methods relating to antibodies specific for the soluble form of CTLA-4 (sCT-LA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021127217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108430499-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019241730-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022006179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020227159-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023278641-A1 |
| priorityDate |
2009-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |